Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Auclair

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
The International Journal of Neuropsychopharmacology|January 12, 2010
F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activityMarie-Bernadette Assié, Laurent Bardin, Agnès L Auclair, et al.
Neuropharmacology|March 19, 2013
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxietyA L Auclair, J C Martel, M B Assié, et al.
European Journal of Pharmacology|October 16, 2020
Pharmacology profile of F17464, a dopamine D<sub>3</sub> receptor preferential antagonistCristina Cosi, Jean-Claude Martel, Agnès L Auclair, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
The International Journal of Neuropsychopharmacology|January 12, 2010
F15599, a highly selective post-synaptic 5-HT(1A) receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activityMarie-Bernadette Assié, Laurent Bardin, Agnès L Auclair, et al.
Neuropharmacology|March 19, 2013
Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxietyA L Auclair, J C Martel, M B Assié, et al.
European Journal of Pharmacology|October 16, 2020
Pharmacology profile of F17464, a dopamine D<sub>3</sub> receptor preferential antagonistCristina Cosi, Jean-Claude Martel, Agnès L Auclair, et al.
Pageof 5